Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jounce Therapeutics Inc (NQ: JNCE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 3, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jounce Therapeutics Inc < Previous 1 2 3 Next > Why Enovix Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket February 23, 2023 Gainers Via Benzinga JNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Jounce Therapeutics, Inc. Is Fair to Shareholders February 23, 2023 From Halper Sadeh LLC Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 23, 2023 We're starting off the day with a look at all the biggest pre-market stock movers traders need to know about on Thursday! Via InvestorPlace Jounce Therapeutics Shares Fall After Disappointing Mid-Stage Lung Cancer Trial Data August 30, 2022 Via Benzinga Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday January 03, 2023 Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market... Via Benzinga Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session December 28, 2022 Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 28, 2022 Via Benzinga Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program December 28, 2022 Via Benzinga Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today? December 28, 2022 Gilead will try to win approval for what is now GS-1811, while Jounce develops other immunotherapy drugs. JNCE stock is soaring. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 28, 2022 Via Benzinga Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket December 28, 2022 Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. Via Benzinga Cal-Maine Foods, Kala Pharmaceuticals And 3 Stocks To Watch Heading Into Wednesday December 28, 2022 With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics December 27, 2022 From Gilead Sciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session December 22, 2022 Via Benzinga Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket December 15, 2022 Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday December 13, 2022 On Tuesday, 49 companies hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 05, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday November 15, 2022 On Tuesday, 34 companies set new 52-week lows. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022 November 11, 2022 Upgrades Via Benzinga NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81% November 11, 2022 Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to... Via Benzinga Susquehanna Slashes Price Target On This Stock By 60%; Also Check Out Some Other Major PT Changes August 31, 2022 Susquehanna cut the price target on Paysafe Limited (NYSE: PSFE) from $5 to $2. Susquehanna analyst James Friedman also downgraded the stock from Positive to Neutral. Paysafe shares fell 1.7% to $1.79... Via Benzinga Stocks That Hit 52-Week Lows On Friday November 11, 2022 On Friday, 63 stocks hit new 52-week lows. Via Benzinga Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary August 30, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 30, 2022 Via Benzinga Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday November 11, 2022 Gainers Via Benzinga Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday August 31, 2022 Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float. Via Benzinga Earnings Outlook For Jounce Therapeutics August 03, 2022 Jounce Therapeutics (NASDAQ:JNCE) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Jounce... Via Benzinga Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session August 30, 2022 Gainers NewAge, Inc. (NASDAQ: NBEV) rose 54.4% to $0.3220. Via Benzinga Stocks That Hit 52-Week Lows On Thursday June 02, 2022 During the Thursday's session, 100 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday June 01, 2022 On Wednesday, 73 stocks hit new 52-week lows. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.